Tender Offer - IGM Biosciences, Inc.

Form Type: SC14D9C

Filing Date: 2025-07-01

Corporate Action: Tender-offer

Type: New

Accession Number: 000119312525153739

Filing Summary: On July 1, 2025, IGM Biosciences, Inc. announced the execution of an Agreement and Plan of Merger with Concentra Biosciences, LLC and its acquisition subsidiary, which involves a tender offer to acquire all outstanding shares of IGM's common stock at a price of $1.247 per share in cash and including one contingent value right. The Offer has not commenced yet and is subject to conditions outlined in the Merger Agreement. The communication includes preliminary disclosures and a cautionary note regarding forward-looking statements. Investors are urged to read the tender offer materials when available, as these will contain significant information for decision-making regarding share tendering.